Who we are
About
David Rutledge
President & CEO at Global Strategic Solutions, LLC
David R Rutledge, Pharm.D., FCCP, FAHA is a results-oriented consultant for clinical evaluation and investigation, clinical risk management, regulatory, and quality. He brings 25 years’ global experience with agencies such as US FDA, Brazil ANVISA, Mexico COFEPRIS, NMPA (China FDA), S Korea Ministry of Food and Drug Safety, Hong Kong, Malaysia, Health Canada, Australia TGA, Thailand FDA, Japan PMDA, EMA, Saudi FDA, CDSCO of India and several Notified Bodies, e.g., BSI, DEKRA, Medcert, and TÜV SÜD. He previously accepted a 4-year appointment from the United States Department of Health & Human Services to serve as the Industry Representative on the FDA’s General Hospital and Personal Use Devices Advisory Committee in FDA’s Center for Devices and Radiological Health (CDRH). He is certified as a Lead Auditor for Quality Management Systems ISO13485 and holds certificates for Design Control, Risk Management, Six Sigma and CAPA. He qualified as an EU Person Responsible for Regulatory Compliance (PRRC) March 2021. Dr. David R Rutledge was formerly a Director with Abbott Medical Devices in Global Clinical Research and then Global Regulatory Operations. He has managed budgets up to $23.3 million.
Individual approach
Why choose us
Active In China
Our service area stretches from California to China.
Highly Experienced
Flexible Schedule
Willing to travel
strong work ethic
numerous resources
strong team
“,”nextArrow”:”“,”autoplay”:true,”autoplaySpeed”:4000,”rtl”:false}’ dir=”ltr”>
Uncategorized
Three Reasons Not To Hire A Consultant
Uncategorized
3 Medical Device Startups to Look Out For
Uncategorized
Knowing These Core Elements of a Quality Management System Can Get You Promoted
Uncategorized
Biocompatibility Standards and FDA Guidance: Easy to understand and opportunities for professional development
Medical Devices
What is The Difference Between Quality Control and Quality Assurance?
Data
Document Control Systems: What You Need to Know
Data
What Is The Difference Between Clinical Evaluation and Clinical Investigation?
Podcasts
Creation of Sufficient Clinical Evidence – RAPS 2020 Workshop Introduction
Podcasts
Potential Benefit versus Potential Risk (Residual Risk)